These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 19559712)

  • 1. Structure of the murine unglycosylated IgG1 Fc fragment.
    Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
    J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refined structure of an intact IgG2a monoclonal antibody.
    Harris LJ; Larson SB; Hasel KW; McPherson A
    Biochemistry; 1997 Feb; 36(7):1581-97. PubMed ID: 9048542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling.
    Boehm MK; Woof JM; Kerr MA; Perkins SJ
    J Mol Biol; 1999 Mar; 286(5):1421-47. PubMed ID: 10064707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycobiology: 'the function of sugar in the IgG molecule'.
    Dwek RA; Lellouch AC; Wormald MR
    J Anat; 1995 Oct; 187 ( Pt 2)(Pt 2):279-92. PubMed ID: 7591992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain.
    Raju TS; Scallon BJ
    Biochem Biophys Res Commun; 2006 Mar; 341(3):797-803. PubMed ID: 16442075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.
    Sondermann P; Kaiser J; Jacob U
    J Mol Biol; 2001 Jun; 309(3):737-49. PubMed ID: 11397093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization of a mutated, ADCC-enhanced human Fc fragment.
    Oganesyan V; Damschroder MM; Leach W; Wu H; Dall'Acqua WF
    Mol Immunol; 2008 Apr; 45(7):1872-82. PubMed ID: 18078997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1.
    Matsumiya S; Yamaguchi Y; Saito J; Nagano M; Sasakawa H; Otaki S; Satoh M; Shitara K; Kato K
    J Mol Biol; 2007 May; 368(3):767-79. PubMed ID: 17368483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting IgG structures reveal extreme asymmetry and flexibility.
    Saphire EO; Stanfield RL; Crispin MD; Parren PW; Rudd PM; Dwek RA; Burton DR; Wilson IA
    J Mol Biol; 2002 May; 319(1):9-18. PubMed ID: 12051932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.
    Krapp S; Mimura Y; Jefferis R; Huber R; Sondermann P
    J Mol Biol; 2003 Jan; 325(5):979-89. PubMed ID: 12527303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of deglycosylated human IgG4-Fc.
    Davies AM; Jefferis R; Sutton BJ
    Mol Immunol; 2014 Nov; 62(1):46-53. PubMed ID: 24956411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex.
    Sondermann P; Huber R; Oosthuizen V; Jacob U
    Nature; 2000 Jul; 406(6793):267-73. PubMed ID: 10917521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and stability changes of human IgG1 Fc as a consequence of methionine oxidation.
    Liu D; Ren D; Huang H; Dankberg J; Rosenfeld R; Cocco MJ; Li L; Brems DN; Remmele RL
    Biochemistry; 2008 May; 47(18):5088-100. PubMed ID: 18407665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific N-glycosylation of chicken serum IgG.
    Suzuki N; Lee YC
    Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
    Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
    Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.
    Mimura Y; Ashton PR; Takahashi N; Harvey DJ; Jefferis R
    J Immunol Methods; 2007 Sep; 326(1-2):116-26. PubMed ID: 17714731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.
    Lund J; Takahashi N; Pound JD; Goodall M; Jefferis R
    J Immunol; 1996 Dec; 157(11):4963-9. PubMed ID: 8943402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
    Raju TS
    Curr Opin Immunol; 2008 Aug; 20(4):471-8. PubMed ID: 18606225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended flexible linker structures in the complement chimaeric conjugate CR2-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
    Gilbert HE; Aslam M; Guthridge JM; Holers VM; Perkins SJ
    J Mol Biol; 2006 Feb; 356(2):397-412. PubMed ID: 16375923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.